Tech Company Financing Transactions
MolecularMD Funding Round
MolecularMD closed a $2.1 million investment round on 2/13/2017. Investors included private investors.
Transaction Overview
Company Name
Announced On
2/13/2017
Transaction Type
Venture Equity
Amount
$2,070,300
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 7 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1341 SW. Custer Dr.
Portland, OR 97219
USA
Portland, OR 97219
USA
Phone
Website
Email Address
Overview
Founded in 2006, MolecularMD is a molecular diagnostics company specializing in clinical development and commercialization of state-of-the-art genomic assays to measure patient response and resistance to targeted cancer therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Snyder
Chief Financial Officer
Ryan Dunlap
Chief Marketing Officer
Fritz Eibel
Chief Medical Officer
Chad Galderisi
VP - Regulatory Affairs
Cindy Spittle
Browse more venture capital transactions:
Prev: 2/13/2017: Sure venture capital transaction
Next: 2/13/2017: SquadLocker venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs